Using GANs for De Novo Protein Design Targeting Microglial IL-3R$α$ to Inhibit Alzheimer's Progression
IL-3 is a hemopoietic growth factor that usually targets blood cell precursors; IL-3R is a cytokine receptor that binds to IL-3. However, IL-3 takes on a different role in the context of glial cells in the nervous system, where studies show that the protein IL-3 protects against Alzheimer's disease by activating microglia at their IL-3R receptors, causing the microglia to clear out the tangles caused by the build-up of misfolded Tau proteins. In this study, we seek to ascertain what role the secondary structure of IL-3 plays in its binding with the receptor. The motivation behind this study is to learn more about the mechanism and identify possible drugs that might be able to activate it, in hopes of inhibiting the spread of Alzheimer's Disease. From a preliminary analysis of complexes containing IL-3 and IL-3R, we hypothesized that the binding is largely due to the interactions of three alpha helix structures stretching towards the active site on the receptor. The original Il-3 protein serves as the control in this experiment; the other proteins being tested are generated through several types of computational de novo protein design, where machine learning allows for the production of entirely novel structures. The efficacy of the generated proteins is assessed through docking simulations with the IL-3R receptor, and the binding poses are also qualitatively examined to gain insight into the function of the binding. From the docking data and poses, the most successful proteins were those with similar secondary structure to IL-3.
Code (0)
등록된 구현이 없습니다.
Tasks
Protein DesignSimilar Papers 제목 키워드 기반
Conditional Generative Modeling for De Novo Hierarchical Multi-Label Functional Protein Design
The availability of vast protein sequence information and rich functional annotations thereof has a large potential for protein design applications in biomedicine and synthetic biology. To this date, there exists no meth…
Protein DesignvalidA Comprehensive Review of Emerging Approaches in Machine Learning for De Novo PROTAC Design
Targeted protein degradation (TPD) is a rapidly growing field in modern drug discovery that aims to regulate the intracellular levels of proteins by harnessing the cell's innate degradation pathways to selectively target…
Drug DesignDrug DiscoveryGenerative modeling for protein structures
Analyzing the structure and function of proteins is a key part of understanding biology at the molecular and cellular level. In addition, a major engineering challenge is to design new proteins in a principled and method…
Protein DesignCross-Chirality Generalization by Axial Vectors for Hetero-Chiral Protein-Peptide Interaction Design
D-peptide binders targeting L-proteins have promising therapeutic potential. Despite rapid advances in machine learning-based target-conditioned peptide design, generating D-peptide binders remains largely unexplored. In…
Protein DesignGenerative De Novo Protein Design with Global Context
The linear sequence of amino acids determines protein structure and function. Protein design, known as the inverse of protein structure prediction, aims to obtain a novel protein sequence that will fold into the defined …
Protein DesignProtein Structure Prediction